James Faulconbridge Purchases 1,500 Shares of Hawkins (NASDAQ:HWKN) Stock

Hawkins, Inc. (NASDAQ:HWKN) Director James Faulconbridge purchased 1,500 shares of the firm’s stock in a transaction on Wednesday, February 4th. The stock was bought at an average cost of $129.29 per share, for a total transaction of $193,935.00. Following the completion of the purchase, the director directly owned 50,907 shares in the company, valued at approximately $6,581,766.03. This trade represents a 3.04% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.

Hawkins Stock Performance

NASDAQ:HWKN opened at $134.38 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.46 and a current ratio of 2.35. Hawkins, Inc. has a fifty-two week low of $98.30 and a fifty-two week high of $186.15. The firm has a market cap of $2.81 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 2.84 and a beta of 0.86. The business has a 50 day moving average price of $144.54 and a 200-day moving average price of $155.13.

Hawkins (NASDAQ:HWKN) last issued its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 EPS for the quarter, missing the consensus estimate of $0.75 by ($0.03). The firm had revenue of $244.08 million during the quarter, compared to analysts’ expectations of $252.51 million. Hawkins had a return on equity of 16.85% and a net margin of 7.75%. Equities research analysts predict that Hawkins, Inc. will post 4 earnings per share for the current year.

Hawkins Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be paid a $0.19 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Hawkins’s dividend payout ratio (DPR) is presently 19.24%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Salomon & Ludwin LLC purchased a new stake in Hawkins in the third quarter worth about $27,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new position in Hawkins during the 2nd quarter valued at approximately $31,000. First Horizon Corp purchased a new position in Hawkins during the third quarter valued at $34,000. Sound Income Strategies LLC bought a new stake in Hawkins in the fourth quarter worth $34,000. Finally, Aster Capital Management DIFC Ltd grew its stake in shares of Hawkins by 62.2% in the third quarter. Aster Capital Management DIFC Ltd now owns 300 shares of the specialty chemicals company’s stock worth $55,000 after acquiring an additional 115 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors.

Hawkins News Roundup

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Director James A. Faulconbridge increased his stake, purchasing 1,500 shares at an average $129.29 (total ~$193,935), bringing his holdings to ~50,907 shares (worth ~ $6.58M). Insider buying by a director is typically viewed as a confidence signal and likely helped lift the stock. Top Insider Just Made a Big Bet on This Under-the-Radar Company SEC Form 4
• Neutral Sentiment: Reported short interest shows 0 shares and a 0.0 days-to-cover ratio — this appears to be a reporting artifact or a very low short interest reading. Low/zero short interest reduces short-squeeze risk but offers limited directional insight. (Source: market data entry)
• Negative Sentiment: Sidoti (coverage) trimmed its FY2027 EPS estimate for Hawkins from $5.10 to $4.60 and published a cautious near-term view; the firm projects FY2028 at $5.10 and Q3 2028 at $1.01. Analyst downgrades can pressure the stock by lowering near-term expectations and investor sentiment. Sidoti Csr Has Pessimistic View of Hawkins FY2026 Earnings

Analyst Ratings Changes

Several research firms have weighed in on HWKN. Zacks Research upgraded Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. Weiss Ratings lowered Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Finally, BWS Financial reiterated a “buy” rating and issued a $200.00 price target on shares of Hawkins in a report on Thursday, January 29th. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Hawkins has an average rating of “Hold” and an average price target of $162.50.

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.